77 related articles for article (PubMed ID: 6091631)
1. Effect of native and synthetic atrial natriuretic factor on cyclic GMP.
Hamet P; Tremblay J; Pang SC; Garcia R; Thibault G; Gutkowska J; Cantin M; Genest J
Biochem Biophys Res Commun; 1984 Sep; 123(2):515-27. PubMed ID: 6091631
[TBL] [Abstract][Full Text] [Related]
2. PDE9A deficiency does not prevent chronic-hypoxic pulmonary hypertension in mice.
Kolb TM; Johnston L; Damarla M; Kass DA; Hassoun PM
Physiol Rep; 2021 Sep; 9(18):e15057. PubMed ID: 34569183
[TBL] [Abstract][Full Text] [Related]
3. The B-type natriuretic peptide of the Congo and Timneh grey parrot.
Hennig A; Mohr L; Fehr M; Legler M
Vet Res Commun; 2021 Dec; 45(4):329-333. PubMed ID: 34278549
[TBL] [Abstract][Full Text] [Related]
4. A new small molecule inhibitor of soluble guanylate cyclase.
Mota F; Gane P; Hampden-Smith K; Allerston CK; Garthwaite J; Selwood DL
Bioorg Med Chem; 2015 Sep; 23(17):5303-10. PubMed ID: 26264842
[TBL] [Abstract][Full Text] [Related]
5. Maternal hypertension programs increased cerebral tissue damage following stroke in adult offspring.
Ventura NM; Jin AY; Tse MY; Peterson NT; Andrew RD; Mewburn JD; Pang SC
Mol Cell Biochem; 2015 Oct; 408(1-2):223-33. PubMed ID: 26169981
[TBL] [Abstract][Full Text] [Related]
6. Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.
Pandey KN
Front Mol Neurosci; 2014; 7():75. PubMed ID: 25202235
[TBL] [Abstract][Full Text] [Related]
7. Membrane guanylate cyclase, a multimodal transduction machine: history, present, and future directions.
Sharma RK; Duda T
Front Mol Neurosci; 2014; 7():56. PubMed ID: 25071437
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptide receptor-C agonist attenuates the expression of cell cycle proteins and proliferation of vascular smooth muscle cells from spontaneously hypertensive rats: role of Gi proteins and MAPkinase/PI3kinase signaling.
El Andalousi J; Li Y; Anand-Srivastava MB
PLoS One; 2013; 8(10):e76183. PubMed ID: 24155894
[TBL] [Abstract][Full Text] [Related]
9. Dynamic genetic linkage of intermediate blood pressure phenotypes during postural adaptations in a founder population.
Arenas IA; Tremblay J; Deslauriers B; Sandoval J; Šeda O; Gaudet D; Merlo E; Kotchen T; Cowley AW; Hamet P
Physiol Genomics; 2013 Feb; 45(4):138-50. PubMed ID: 23269701
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific differences in natriuretic peptide and nitric oxide synthase expression in ANP gene-disrupted mice.
Wong PG; Armstrong DW; Tse MY; Brander EP; Pang SC
Mol Cell Biochem; 2013 Feb; 374(1-2):125-35. PubMed ID: 23180242
[TBL] [Abstract][Full Text] [Related]
11. Ca(2+) modulation of ANF-RGC: new signaling paradigm interlocked with blood pressure regulation.
Duda T; Pertzev A; Sharma RK
Biochemistry; 2012 Nov; 51(46):9394-405. PubMed ID: 23088492
[TBL] [Abstract][Full Text] [Related]
12. GREBP, a cGMP-response element-binding protein repressing the transcription of natriuretic peptide receptor 1 (NPR1/GCA).
Martel G; Hamet P; Tremblay J
J Biol Chem; 2010 Jul; 285(27):20926-39. PubMed ID: 20444705
[TBL] [Abstract][Full Text] [Related]
13. Membrane guanylate cyclase is a beautiful signal transduction machine: overview.
Sharma RK
Mol Cell Biochem; 2010 Jan; 334(1-2):3-36. PubMed ID: 19957201
[TBL] [Abstract][Full Text] [Related]
14. Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome.
Martel G; Hamet P; Tremblay J
Mol Cell Biochem; 2010 Jan; 334(1-2):53-65. PubMed ID: 19937369
[TBL] [Abstract][Full Text] [Related]
15. Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation.
Pandey KN
J Am Soc Hypertens; 2008; 2(4):210-26. PubMed ID: 19746200
[TBL] [Abstract][Full Text] [Related]
16. A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases.
Kots AY; Martin E; Sharina IG; Murad F
Handb Exp Pharmacol; 2009; (191):1-14. PubMed ID: 19089322
[TBL] [Abstract][Full Text] [Related]
17. Neutral endopeptidase inhibitor suppresses the early phase of atrial electrical remodeling in a canine rapid atrial pacing model.
Imaki R; Niwano S; Niwano H; Satoh D; Yoshida T; Masaki Y; Izumi T
Indian Pacing Electrophysiol J; 2008 Apr; 8(2):102-13. PubMed ID: 18379655
[TBL] [Abstract][Full Text] [Related]
18. Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis.
Maeshiro K; Takamori S; Mifune H; Matsuo T; Kimura NY; Honda J; Shirouzu K
Surg Today; 2008; 38(2):130-4. PubMed ID: 18239869
[TBL] [Abstract][Full Text] [Related]
19. Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.
Pagel-Langenickel I; Buttgereit J; Bader M; Langenickel TH
J Mol Med (Berl); 2007 Aug; 85(8):797-810. PubMed ID: 17429599
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptides elevate cyclic GMP levels in primary cultures of rat ependymal cells.
Wellard J; Rapp M; Hamprecht B; Verleysdonk S
Neurochem Res; 2003 Feb; 28(2):225-33. PubMed ID: 12608696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
